Effect of surgical intervention on circulating tumor cells in patients with squamous cell carcinoma of the head and neck using a negative enrichment technology

被引:20
|
作者
Jatana, Kris R. [1 ,2 ]
Balasubramanian, Priya [3 ]
McMullen, Kyle P. [2 ]
Lang, Jas C. [2 ]
Teknos, Theodoros N. [2 ]
Chalmers, Jeffrey J. [3 ]
机构
[1] Nationwide Childrens Hosp, Dept Pediat Otolaryngol Head & Neck Surg, Columbus, OH USA
[2] Ohio State Univ, Dept Otolaryngol Head & Neck Surg, Wexner Med Ctr, Columbus, OH 43210 USA
[3] Ohio State Univ, William G Lowrie Dept Chem & Biomol Engn, Columbus, OH 43210 USA
基金
美国国家科学基金会;
关键词
circulating tumor cell; squamous cell carcinoma; surgery; immunomagnetic separation; EPITHELIAL-MESENCHYMAL TRANSITION; LYMPH-NODE METASTASIS; BONE-MARROW; CANCER PATIENTS; LUNG-CANCER; PROGNOSTIC-SIGNIFICANCE; PERIPHERAL-BLOOD; BREAST-CANCER; DISSEMINATION; RISK;
D O I
10.1002/hed.24519
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Background. The purpose of this study was to investigate the impact of surgical intervention on detection of circulating tumor cells (CTCs) in patients with squamous cell carcinoma of the head and neck (SCCHN.) Methods. We utilized a negative depletion technique to identify cytokeratin (CK)-positive CTCs. The numbers of CTCs immediately before and after surgical resection were compared. Results. Seventy-six blood samples from 38 patients with SCCHN were examined. Seventy-nine percent of the patients had CTCs detected before and after surgery. A total of 7.89% had no CTCs before surgery, yet had CTCs identified after surgery. Overall, 60.5% of patients had an increased number of CTCs/mL after surgery with a mean increase of 6.63-fold. A statistically significant increase in CTCs was seen after surgery (p = .02). Conclusion. The timing of sample collection in patients with SCCHN who have surgical intervention can potentially impact the number of CTCs identified. (C) 2016 Wiley Periodicals, Inc.
引用
收藏
页码:1799 / 1803
页数:5
相关论文
共 50 条
  • [41] Behavior of circulating tumor cells in patients with locally advanced squamous cell carcinoma of the head and neck during therapy: A prospective study
    Inhestern, J.
    Stemmann, V.
    Pachmann, K.
    Guntinas-Lichius, O.
    ORAL ONCOLOGY, 2015, 51 (05) : E54 - E55
  • [42] Prognostic value of circulating tumor cells with podoplanin expression in patients with locally advanced or metastatic head and neck squamous cell carcinoma
    Hsieh, Jason Chia-Hsun
    Lin, Hung-Chih
    Huang, Chi-Ya
    Hsu, Hsung-Ling
    Wu, Tyler Min-Hsien
    Lee, Chia-Lin
    Chen, Min-Chi
    Wang, Hung-Ming
    Tseng, Ching-Ping
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2015, 37 (10): : 1448 - 1455
  • [43] Circulating tumor cell analysis in locally advanced and metastatic squamous cell carcinoma of the head and neck
    Harris, Ethan J.
    Huang, Julian
    Carroll, Erin
    Lowe, Alarice C.
    Chau, Nicole G.
    Rabinowits, Guilherme
    Haddad, Robert
    Hanna, Glenn J.
    Haddad, Tyler
    Sanborn, Matthew
    Kacew, Alec
    Lorch, Jochen
    LARYNGOSCOPE INVESTIGATIVE OTOLARYNGOLOGY, 2020, 5 (06): : 1063 - 1069
  • [44] Circulating tumor DNA as a biomarker and liquid biopsy in head and neck squamous cell carcinoma
    Payne, Karl
    Spruce, Rachel
    Beggs, Andrew
    Sharma, Neil
    Kong, Anthony
    Martin, Timothy
    Parmar, Satyesh
    Praveen, Prav
    Nankivell, Paul
    Mehanna, Hisham
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2018, 40 (07): : 1598 - 1604
  • [45] Comparison of tumor markers in patients with squamous cell carcinoma of the head and neck
    Ogawa, T
    Tsurusako, Y
    Kimura, N
    Nishioka, S
    Akagi, H
    Nishizaki, K
    Nishioka, K
    Rutka, J
    ACTA OTO-LARYNGOLOGICA, 1999, : 72 - 76
  • [46] Imbalance of circulating monocyte subsets in patients with squamous cell carcinoma of the head and neck
    Sakakura, Koichi
    Takahashi, Hideyuki
    Motegi, Sei-ichiro
    Chikamatsu, Kazuaki
    CANCER RESEARCH, 2016, 76
  • [47] The effect of circulating tumor DNA on the prognosis of patients with head and neck squamous cell carcinoma: a systematic review and meta-analysis
    Yang, Ruoyi
    Li, Teng
    Zhang, Sicheng
    Shui, Chunyan
    Ma, Hong
    Li, Chao
    BMC CANCER, 2024, 24 (01)
  • [48] Detection of circulating tumor DNA in operable locoregionally advanced HPV-negative head and neck squamous cell carcinoma
    Beaussire, L.
    Berghian, A.
    Bohers, E.
    Viennot, M.
    Libraire, J.
    Mardion, N. Bon
    Meret, E.
    Obongo, R.
    Sarafan-vasseur, N.
    Di Fiore, F.
    Clatot, F.
    ANNALS OF ONCOLOGY, 2023, 34 : S563 - S563
  • [49] PDL1-expressing circulating tumor cells (CTCs) in head and neck squamous cell carcinoma (HNSCC).
    Koutsodontis, George
    Strati, Areti
    Avgeris, Margaritis
    Maratou, Eirini
    Ramfidis, Vassilios
    Konstantinidis, George
    Economopoulou, Panagiota
    Kotsantis, Giannis
    Tsigaridas, Kostas
    Vagia, Elena Mihal
    Haralambakis, Nick
    Sasaki, Clarence
    Scorilas, Andreas
    Perisanidis, Christos
    Vasilakopoulou, Maria
    Strimpakos, Alexios
    Lianidou, Evi
    Psyrri, Amanda
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [50] Prognostic relevance of molecular characterization of circulating tumor cells (CTC) in head and neck squamous cell carcinoma (HNSCC)
    Koutsodontis, G.
    Strati, A.
    Papaxoinis, G.
    Charalambakis, N.
    Kotsantis, I.
    Oikonomopoulou, P.
    Hoxhallari, L.
    Lianidou, E.
    Psyrri, A.
    ANNALS OF ONCOLOGY, 2016, 27